it is clear we are coming to a moment that it is obvious that something is on the brink to happen
Yes voodoo, something is going to happen, the problem is we do not know what it is, and the likelyhood is, it will be GTC ending up as property of the French at a very low PPS.
So ok forget these start ups
I fear you do not understand my post. My post is not about BOD's attitudes. It is about how the drug industry and the FDA are constituted and arrayed in a way that currently leaves GTC's NPPP little room to enter the market place. This is not related to bias or part of a conspiracy, but results from the historical method of how a drug gets through to the market, and is inadvertantly aided by the FDA rule which declares a biotherapeutic's method of production, is a intergral part of its identity. In this notion I am contadicting Vinny's opinion that BP's lack of interest was a worry transgenics would "never get through the FDA".
As far as the coincidence of the ATryn approval and the Ovation deal, I am flattered you are repeating a message from my post following the Lundbeck buyout. (see DIC and Deception)
JL